How does mirtazapine work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

How Mirtazapine Works

Mirtazapine enhances noradrenergic and serotonergic neurotransmission by blocking presynaptic α2-adrenergic autoreceptors and heteroreceptors, while simultaneously antagonizing postsynaptic 5-HT2 and 5-HT3 receptors, resulting in selective enhancement of 5-HT1A-mediated serotonergic activity. 1

Primary Mechanism of Action

The FDA-approved mechanism centers on dual noradrenergic and serotonergic enhancement through a unique antagonist profile 1:

Noradrenergic Effects

  • Blocks presynaptic α2-adrenergic autoreceptors → increases norepinephrine release
  • Blocks α2-heteroreceptors on serotonin neurons → removes inhibitory control on serotonin release
  • The affinity is 10-fold higher for central presynaptic α2-receptors than peripheral receptors 2

Serotonergic Effects

  • Does NOT inhibit serotonin reuptake (unlike SSRIs)
  • Potently blocks 5-HT2 and 5-HT3 receptors while having minimal affinity for 5-HT1A/1B receptors 1
  • The net result: only 5-HT1A-mediated transmission is enhanced 3
  • This selective enhancement occurs because mirtazapine blocks the "unwanted" serotonin receptor subtypes while allowing increased serotonin to act at 5-HT1A receptors

The Cascade Effect

The mechanism works through an elegant cascade 3, 4:

  1. Norepinephrine release increases (via α2-autoreceptor blockade)
  2. This norepinephrine stimulates α1-receptors on serotonin neurons → increases serotonergic cell firing in the dorsal raphe
  3. Simultaneously, α2-heteroreceptor blockade removes inhibition of serotonin release in the hippocampus
  4. Result: Increased serotonin release that acts selectively at 5-HT1A receptors (because 5-HT2 and 5-HT3 are blocked)

This dual enhancement of noradrenergic and specific serotonergic (5-HT1A) transmission is termed NaSSA (Noradrenergic and Specific Serotonergic Antidepressant) 3, 4.

Additional Receptor Actions Explaining Side Effects

Beyond the antidepressant mechanism, mirtazapine antagonizes 1:

  • Histamine H1 receptors → explains prominent sedation (useful for insomnia in depression)
  • Peripheral α1-adrenergic receptors → explains orthostatic hypotension risk
  • Minimal muscarinic receptor activity → low anticholinergic effects

Critical clinical point: The sedation from H1 blockade and appetite increase are side effects, NOT the therapeutic mechanism 5.

Clinical Implications of This Mechanism

Advantages Over SSRIs

  • No sexual dysfunction (because 5-HT2 and 5-HT3 blockade prevents these serotonergic side effects) 4
  • Fewer GI side effects (5-HT3 blockade prevents nausea/diarrhea) 5
  • May have faster onset (2-4 weeks, with sleep/anxiety improving in week 1) 6, 5

Common Pitfalls

  • Weight gain and increased appetite occur in ~10% (vs 1% placebo) due to H1 and 5-HT2C antagonism 6
  • Sedation is prominent (23% vs 14% placebo) - dose at bedtime 5
  • The mechanism does NOT involve monoamine reuptake inhibition, so it has a distinct side effect profile from SSRIs/SNRIs

Pharmacokinetic Considerations

  • Half-life: 20-40 hours → enables once-daily dosing 1
  • Bioavailability: ~50% with peak levels at 2 hours 1
  • Metabolism via CYP2D6, CYP1A2, and CYP3A4 1
  • Clearance reduced 40% in elderly males, 10% in elderly females → dose adjustment needed 1

The mechanism is fundamentally different from tricyclics (which block reuptake) and SSRIs (which block serotonin reuptake), making mirtazapine a distinct pharmacologic option when these first-line agents fail or cause intolerable side effects.

References

Related Questions

What is mirtazapine?
What is the recommended starting dose, titration schedule, contraindications, side effects, and monitoring for mirtazapine in an adult with major depressive disorder, especially when insomnia is a primary symptom?
Can mirtazapine be tapered from 30 mg to 15 mg as part of a taper schedule?
Does mirtazapine cause anticholinergic effects and dry mouth, and what as‑needed (PRN) anti‑anxiety medication can be used?
How soon after initiating mirtazapine does sedation typically occur?
With an absolute neutrophil count of 1,400 cells/mm³, can weekly paclitaxel be administered?
In a patient with an absolute neutrophil count of 1,400 cells/mm³ scheduled for weekly paclitaxel, should granulocyte‑colony stimulating factor be given one day before chemotherapy or after the paclitaxel dose?
What is the recommended treatment approach for oligometastatic esophageal squamous cell carcinoma?
In a hospice patient with an acute humeral head fracture whose family declines hospital transfer, should a sling be used for arm support?
What is the mechanism of action of bupropion?
Is melatonin safe for a patient with hyponatremia who has difficulty falling asleep?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.